Search research articles
Contact Us
Filters
Showing results (241-250 of 290) with videos related to
Page
of 29
Sort By:
Journal of Neurochemistry
|
May 8, 1998
Involvement of pituitary adenylate cyclase-activating polypeptide II vasoactive intestinal peptide 2 receptor in mouse neocortical astrocytogenesis
V Zupan, J M Hill, D E Brenneman, et al.
FEBS Letters
|
June 25, 1984
Specific labelling by [125I]helodermin of high-affinity VIP receptors in rat liver membranes
P Robberecht, M Waelbroeck, P de Neef, et al.
Peptides
|
March 1, 1984
Specific decrease of secretin/VIP-stimulated adenylate cyclase in the heart from the Lyon strain of hypertensive rats
P Robberecht, L Gillet, P Chatelain, et al.
Peptides
|
January 1, 1995
Identification of a new chromogranin B fragment (314-365) in endocrine tumors
M C Woussen-Colle, P Gourlet, A Vandermeers, et al.
Endocrinology
|
November 1, 1985
Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes
P Robberecht, D H Coy, M Waelbroeck, et al.
Peptides
|
January 1, 1997
The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass
P Gourlet, P Vertongen, A Vandermeers, et al.
FEBS Letters
|
January 30, 1984
Pancreatic secretory factor (PSF), a protein from Gila monster venom stimulating enzyme secretion from rat pancreatic acini
J P Dehaye, J Winand, P Michel, et al.
Biochimica Et Biophysica Acta
|
July 22, 1991
The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes
P Gourlet, P De Neef, M C Woussen-Colle, et al.
European Journal of Biochemistry
|
July 1, 1992
Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist
P Robberecht, P Gourlet, P De Neef, et al.
Molecular and Cellular Endocrinology
|
January 1, 1995
Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide stimulate two signaling pathways in CHO cells stably transfected with the selective type I PACAP receptor
C Delporte, P Poloczek, P de Neef, et al.
Page
of 29
Search research articles
Search
Showing results (241-250 of 290) with videos related to
Sort By:
Page
of 29
Journal of Neurochemistry
|
May 8, 1998
Involvement of pituitary adenylate cyclase-activating polypeptide II vasoactive intestinal peptide 2 receptor in mouse neocortical astrocytogenesis
V Zupan, J M Hill, D E Brenneman, et al.
FEBS Letters
|
June 25, 1984
Specific labelling by [125I]helodermin of high-affinity VIP receptors in rat liver membranes
P Robberecht, M Waelbroeck, P de Neef, et al.
Peptides
|
March 1, 1984
Specific decrease of secretin/VIP-stimulated adenylate cyclase in the heart from the Lyon strain of hypertensive rats
P Robberecht, L Gillet, P Chatelain, et al.
Peptides
|
January 1, 1995
Identification of a new chromogranin B fragment (314-365) in endocrine tumors
M C Woussen-Colle, P Gourlet, A Vandermeers, et al.
Endocrinology
|
November 1, 1985
Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes
P Robberecht, D H Coy, M Waelbroeck, et al.
Peptides
|
January 1, 1997
The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass
P Gourlet, P Vertongen, A Vandermeers, et al.
FEBS Letters
|
January 30, 1984
Pancreatic secretory factor (PSF), a protein from Gila monster venom stimulating enzyme secretion from rat pancreatic acini
J P Dehaye, J Winand, P Michel, et al.
Biochimica Et Biophysica Acta
|
July 22, 1991
The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes
P Gourlet, P De Neef, M C Woussen-Colle, et al.
European Journal of Biochemistry
|
July 1, 1992
Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist
P Robberecht, P Gourlet, P De Neef, et al.
Molecular and Cellular Endocrinology
|
January 1, 1995
Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide stimulate two signaling pathways in CHO cells stably transfected with the selective type I PACAP receptor
C Delporte, P Poloczek, P de Neef, et al.
Page
of 29